1. AWMF (2012) Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften; Deutsche Krebsgesellschaft; Deutsche Krebshilfe. S3-Leitlinie "Diagnostik und Therapie der Adenokarzinome des Magens und ösophagogastralen Übergangs" [2012]. http://www.awmf.org/uploads/tx_szleitlinien/03209l_S3_Magenkarzinon_Diagnostik_Therapie_Adenokarzinome_Magen_ösophagogastralen_Übergang_2012-02_01.pdf
2. Bernini M, Bencini L, Sacchetti R et al. (2013) Italian Research Group for Gastric Cancer (IRGGC) The Cholegas Study: safety of prophylactic cholecystectomy during gastrectomy for cancer: preliminary results of a multicentric randomized clinical trial. Gastric Cancer 16(3): 370–376
3. Bozzetti F, Bonfanti G, Bufalino R et al. (1982) Adequacy of margins of resection in gastrectomy for cancer. Ann Surg 196(6): 685–690
4. Bozzetti F, Marubini E, Bonfanti G et al. (1999) Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial. Italian Gastrointestinal Tumor Study Group. Ann Surg 230(2): 170–178
5. Clavien PA, Sarr MG, Fong Y, Miyazaki M (eds) (2016) Atlas of upper gastrointestinal and hepato-pancreato-biliary surgery. Springer, Berlin Heidelberg